Extended survival of a patient with gastrointestinal multiple malignancies managed with anti-PD-1 immunotherapy: a case report
In summary, this case underscores the potential effectiveness of a holistic, integrative medical approach in managing advanced multiple malignancies amid drug resistance and disease progression.
Authors
- Wenjian Zhu (ORCID: https://orcid.org/0000-0002-5292-661X)
- Tingting Zhou (ORCID: https://orcid.org/0009-0007-3880-4935)
- Tianhao Guo (ORCID: https://orcid.org/0000-0002-8899-2328)
- Wenli Qiu (ORCID: https://orcid.org/0000-0002-3019-7321)
- Xuan Li (ORCID: https://orcid.org/0000-0001-9352-6375)
- Liu Li (ORCID: https://orcid.org/0000-0002-9746-0067)
- Haibo Cheng (ORCID: https://orcid.org/0000-0003-3329-2225)
- Ke Fei (ORCID: https://orcid.org/0000-0003-0982-9256)
- Yifan Hui (ORCID: https://orcid.org/0000-0003-0364-9449)
Institutions
- Nanjing University of Chinese Medicine (CN)
- Wangjing Hospital of China Academy of Chinese Medical Sciences (CN)
- China Academy of Chinese Medical Sciences (CN)
- Jiangsu Provincial Hospital of Traditional Chinese Medicine (CN)
- Hong Kong Metropolitan University (HK)
Publication Details
- Journal
- Immunotherapy
- Published
- 2025-01-22
- DOI
- https://doi.org/10.1080/1750743x.2025.2463309
- Citations
- 1
- Primary Topic
- Multiple and Secondary Primary Cancers
- Type
- article
- Field-Weighted Citation Impact
- 1.35
Funders
- National Key Research and Development Program of China